BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 28385600)

  • 1. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
    Amer MG; Embaby AS; Karam RA; Amer MG
    Gene; 2018 May; 654():87-94. PubMed ID: 29452233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Stem Cells Ameliorate the Pancreatic Damage Induced by Streptozotocin in Rats?
    El Barky AR; Ezz AAH; Alm-Eldeen AA; Hussein SA; Hafez YA; Mohamed TM
    Can J Diabetes; 2018 Feb; 42(1):61-70. PubMed ID: 28642056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus.
    Li L; Li F; Gao F; Yang Y; Liu Y; Guo P; Li Y
    Cell Tissue Res; 2016 May; 364(2):345-55. PubMed ID: 26650464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat.
    Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN
    Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells.
    Dayer D; Tabar MH; Moghimipour E; Tabandeh MR; Ghadiri AA; Bakhshi EA; Orazizadeh M; Ghafari MA
    Cytotherapy; 2017 Aug; 19(8):937-946. PubMed ID: 28647274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells.
    Jian RL; Mao LB; Xu Y; Li XF; Wang FP; Luo XG; Zhou H; He HP; Wang N; Zhang TC
    Gene; 2015 May; 562(1):107-16. PubMed ID: 25724395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stem cell-derived β-cells: New issue for diabetes cell therapy.
    Aglan HA; Kotob SE; Mahmoud NS; Kishta MS; Ahmed HH
    Tissue Cell; 2024 Feb; 86():102280. PubMed ID: 38029457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Feasibility of bone marrow mesenchymal stem cells differentiation in diabetic pancreatic microenvironment].
    Xie H; Chang C; Jiang J; Li Q; Qi H; Deng C; Li F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 May; 25(5):597-601. PubMed ID: 21675121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved differentiation of umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells by PDX-1 mRNA transfection.
    Van Pham P; Thi-My Nguyen P; Thai-Quynh Nguyen A; Minh Pham V; Nguyen-Tu Bui A; Thi-Tung Dang L; Gia Nguyen K; Kim Phan N
    Differentiation; 2014 Jun; 87(5):200-8. PubMed ID: 25201603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
    Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
    Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy.
    Yu YB; Bian JM; Gu DH
    World J Gastroenterol; 2015 Jun; 21(21):6582-90. PubMed ID: 26074696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice.
    Waseem M; Khan I; Iqbal H; Eijaz S; Usman S; Ahmed N; Alam G; Salim A
    Cell Reprogram; 2016 Oct; 18(5):344-355. PubMed ID: 27500307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.